Back
BioXcel Therapeutics Vs. REX American Resources Industry Stock Comparison
Sell
24
BTAI
BioXcel Therapeutics
Last Price:
2.61
Seasonality Move:
13.65%
Buy
69
REX
REX American Resources
Last Price:
57.00
Seasonality Move:
7.69%
Sell
24
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy, Sell or Hold?
- The current BioXcel Therapeutics [BTAI] share price is $2.63. The Score for BTAI is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- BTAI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
69
REX American Resources (REX)
is a Buy
Is REX American Resources a Buy, Sell or Hold?
- The current REX American Resources [REX] share price is $57.04. The Score for REX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- REX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BTAI Stock Price Chart
What is BioXcel Therapeutics's stock price today?
-
The BioXcel Therapeutics share price today is $2.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing buying pressure, which is a positive indicator for future bullish movement.
REX Stock Price Chart
What is REX American Resources's stock price today?
-
The REX American Resources share price today is $57.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BTAI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 45.09 | Sell |
| Chaikin Money Flow: | 180011 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.61 - 2.85) | Sell |
| Bollinger Bands (100): | (2.61 - 3.33) | Sell |
REX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.89 | Buy |
| Relative Strength Index (14 RSI): | 61.46 | Buy |
| Chaikin Money Flow: | 144027 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.26 - 60.12) | Buy |
| Bollinger Bands (100): | (41.1 - 52.48) | Buy |
BTAI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.71 | Sell |
| 20-day SMA: | 2.7 | Sell |
| 50-day SMA: | 2.9 | Sell |
| 200-day SMA: | 3.9 | Sell |
| 8-day EMA: | 2.71 | Sell |
| 20-day EMA: | 2.73 | Sell |
| 50-day EMA: | 2.85 | Sell |
| 200-day EMA: | 5.59 | Sell |
REX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.38 | Buy |
| 20-day SMA: | 57.19 | Sell |
| 50-day SMA: | 49.49 | Buy |
| 200-day SMA: | 42.36 | Buy |
| 8-day EMA: | 56.4 | Buy |
| 20-day EMA: | 55.19 | Buy |
| 50-day EMA: | 51.25 | Buy |
| 200-day EMA: | 43.38 | Buy |
BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.34 per share, and an increase next year of $1.29 per share.
REX American Resources Earnings Growth & REX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.18 per share, an increase this year of $1.56 per share, and a decrease next year of $1.25 per share.
BioXcel Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
REX American Resources Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||